What is the first-line treatment for hair loss?

First-Line Treatment for Hair Loss

For pattern hair loss (androgenetic alopecia), start with topical minoxidil 5% applied twice daily for both men and women, or consider low-dose oral minoxidil (1 mg daily) as an equally effective alternative with better compliance. 1

Treatment Algorithm

For Male Pattern Hair Loss:

• Primary option: Topical minoxidil 5% solution (TMS) or foam (TMF) twice daily 1
• Alternative primary option: Low-dose oral minoxidil (LDOM) 1 mg daily - equivalent efficacy to topical in controlled trials 1
• Add finasteride 1 mg daily for enhanced results in men 2

For Female Pattern Hair Loss:

• Primary option: Topical minoxidil 5% twice daily (FDA-approved and proven safe/effective in women despite labeling suggesting 2%) 1
• Alternative primary option: LDOM 1 mg daily 1
• Note: Finasteride and dutasteride are contraindicated in women 2

Key Clinical Considerations

Topical vs. Oral Minoxidil Decision Points:

The 2025 guidelines indicate no statistically significant difference in efficacy between 5% topical minoxidil 1-2 times daily and 1 mg oral minoxidil 1. Choose oral minoxidil when:

• Entire scalp is involved (easier application)
• Patient compliance concerns with topical application
• Topical formulation causes skin irritation or contact dermatitis (typically from propylene glycol in solution) 1, 3
• Patient desires to avoid effects on hairstyle 1

Application Instructions for Topical Minoxidil:

• Apply to dry scalp (blow-drying immediately after application reduces absorption by 50%) 1
• Twice daily application is superior to once daily 1
• Less than 5% is absorbed systemically, with 75% absorption occurring within 4 hours 1
• More than twice daily provides no additional benefit 1

Safety Profile

Topical minoxidil has minimal systemic effects:

• Blood pressure and pulse typically unaffected (serum levels well below 21.7 ng/mL threshold for hemodynamic changes) 1
• Headaches in <5% of patients 1
• Hypertrichosis (unwanted facial hair) in ~5% of women using 5% formulation, typically on cheeks 1
• Local reactions: irritation, contact dermatitis (switch to foam if propylene glycol allergy suspected) 1

Low-dose oral minoxidil requires screening:

• Contraindications: hypersensitivity to minoxidil, pheochromocytoma, severe cardiac disease 3
• Precautions: history of arrhythmia (81.8% expert consensus), hypotension <90/60 mmHg (77.3%), kidney impairment (88.4%), dialysis patients (88.4%) 3
• Consider cardiology consultation when precautions/contraindications identified (97.7% expert consensus) 3

Timeline and Adjunctive Therapies

Expect minimum 6 months for clinical improvement with any treatment 4. Initial transient shedding is common and expected 3.

Efficacy enhancers for topical minoxidil (supported by evidence):

• Microneedling
• Low-level laser therapy
• Platelet-rich plasma 1

Common Pitfalls to Avoid

• Don't recommend 2% minoxidil for women - the 5% formulation twice daily is proven safe and more effective despite FDA labeling 1
• Don't apply topical minoxidil to damp hair or blow-dry immediately - significantly reduces absorption 1
• Don't prescribe finasteride/dutasteride to women - contraindicated 2
• Don't overlook propylene glycol allergy - switch to foam formulation if irritation occurs with solution 1